Health Insurance for People with Diabetes in 2026

Option 1: ACA Silver Plan with Cost-Sharing Reductions

For people with diabetes earning between 100% and 250% of the Federal Poverty Level, a Silver plan with cost-sharing reductions (CSRs) is almost always the most valuable option in 2026. CSRs are a subsidy that lowers what a diabetic patient pays at the point of care: deductibles, copays, and out-of-pocket maximums all drop. At 100% to 150% FPL ($15,960 to $23,940 for a single person in 2026), the Silver CSR plan can have a deductible under $300 and an annual out-of-pocket maximum under $1,700. At 151% to 200% FPL ($24,080 to $31,920 for a single person), the out-of-pocket maximum drops to approximately $3,500. At 201% to 250% FPL ($32,060 to $39,900), the out-of-pocket cap is approximately $8,450. For a Type 1 diabetic or an insulin-dependent patient spending $3,000 to $8,000 annually on insulin and CGMs, hitting a lower out-of-pocket maximum first means the plan starts covering 100% far earlier in the plan year.

The critical point for diabetic patients: CSRs are ONLY available on Silver-tier Marketplace plans. A Bronze plan at a similar income will not have reduced cost-sharing, meaning you could face a deductible of $5,000 to $7,000 before the plan pays anything for insulin or supplies. Many Type 1 diabetics and insulin-dependent patients make the mistake of choosing Bronze because the premium is lower, then discover the annual out-of-pocket costs far exceed the premium savings. If your MAGI falls below 250% FPL, Silver with CSRs is the correct choice in 2026, not Bronze. The Premium Tax Credit (PTC) on a Silver plan is exactly the same dollar amount as on a Bronze plan at the same income level, so you capture the credit AND get the lower cost-sharing.

Option 2: ACA Gold or Platinum Plan

For a diabetic patient with MAGI between 250% and 400% of the Federal Poverty Level in 2026, CSRs phase out and you are left choosing between Silver at full cost-sharing and Gold or Platinum at higher premiums with lower cost-sharing. The math depends on how much you spend annually on insulin, CGMs, test strips, pump supplies, and endocrinology visits. A Type 1 diabetic on multiple daily injections or a continuous glucose monitor with an insulin pump typically spends $8,000 to $20,000 on medical expenses per year before insurance. If you will reliably hit the deductible and approach the out-of-pocket maximum, a Gold plan with a lower deductible saves money even though the premium is higher. Run the break-even calculation: (Gold premium minus Silver premium times 12) compared to (Silver deductible minus Gold deductible).

Gold and Platinum plans are fully ACA-compliant and must cover all diabetes-related essential health benefits without pre-existing condition exclusions. Prescription drug formularies on Gold and Platinum plans typically include preferred insulin brands at lower tier copays. Verify before enrolling that your specific insulin formulation (rapid-acting, long-acting, biosimilar) is on the plan's formulary at a favorable tier. Some marketplace plans also offer $0 copay for certain diabetes management services, including A1C testing, retinal eye exams, and medical nutrition therapy when billed as preventive care.

Option 3: HSA-Qualified HDHP with Health Savings Account

An HSA-qualified High-Deductible Health Plan paired with a Health Savings Account makes sense for a diabetic patient in limited circumstances: MAGI above 400% FPL ($63,840 single, $132,000 family of four in 2026) so the Premium Tax Credit is not available, AND the condition is relatively well-controlled with a predictable, moderate annual supply cost. A Type 2 diabetic managing with oral medication (metformin) and annual A1C monitoring may spend $1,000 to $3,000 per year, making the HDHP's lower premium and HSA deduction attractive. A Type 1 diabetic or insulin-dependent patient with high Rx volume who would blow through the HDHP deductible ($1,700 self-only minimum in 2026) in January may find a richer plan covers more total cost even at full sticker price.

The triple tax advantage of an HSA is especially valuable for a diabetic patient: HSA contributions are tax-deductible above the line (up to $4,400 self-only or $8,750 family in 2026, plus a $1,000 catch-up at age 55+), growth is tax-free, and qualified withdrawals are tax-free. IRS-confirmed HSA-eligible diabetes expenses include insulin (all formulations), continuous glucose monitors (CGMs) including Dexcom Stelo and FreeStyle Libre OTC versions, test strips, lancets, syringes, insulin pens, and insulin pumps and their supplies. A diabetic patient who funds an HSA and pays out of pocket for predictable annual expenses allows HSA dollars to grow for higher medical costs later. Important: FSA accounts are employer-sponsored only. Most self-employed diabetic patients and gig workers with diabetes do not have access to an FSA and must use an HSA instead.

Option 4: Medicaid in Expansion States

Medicaid in the 40 states (plus DC) that expanded eligibility under the ACA covers people with diabetes with household income under 138% FPL ($22,025 for a single person in 2026). Medicaid is frequently the strongest plan available for a diabetic patient at low income: premiums are $0, and most state Medicaid programs cover insulin, syringes, blood glucose meters, test strips, and CGMs with $0 to $4 copays. The coverage is comprehensive because federal Medicaid rules require coverage of the same essential health benefits as Marketplace plans, and many states go further with enhanced diabetes disease management programs. Diabetic patients in non-expansion states (Florida, Georgia, Texas, Wisconsin, and others) with income under 100% FPL fall into the coverage gap and should investigate Federally Qualified Health Centers (FQHCs) for sliding-scale care.

Medicaid coverage for diabetes supplies varies by state, particularly for advanced devices. Continuous glucose monitors and insulin pump supplies may require prior authorization in some state Medicaid programs, especially for Type 2 diabetics who are not insulin-dependent. Enrollment in Medicaid is year-round with no Open Enrollment window, and gaining or losing Medicaid eligibility is itself a Marketplace Special Enrollment Period trigger. If a Type 1 diabetic or insulin-dependent patient loses Medicaid due to a Medicaid redetermination or income increase, they have 60 days from the loss of coverage date to enroll in a Marketplace plan.

Premium Tax Credit (PTC) eligibility for people with diabetes in 2026

People with diabetes who enroll in an ACA Marketplace plan qualify for the Premium Tax Credit (PTC) based on income alone, not health status. Having a diabetes diagnosis does not reduce, delay, or eliminate PTC eligibility in any way. The 2026 PTC calculation uses one number: your Modified Adjusted Gross Income (MAGI) compared to the Federal Poverty Level. The enhanced PTCs from the American Rescue Plan Act (signed March 2021) and the Inflation Reduction Act (signed August 2022) expired January 1, 2026. The subsidy cliff is back: PTC phases down as income climbs toward 400% FPL and stops entirely at 400% FPL ($63,840 for a single person, $132,000 for a household of four in 2026). A diabetic patient earning $64,000 as a single filer receives $0 in premium tax credits and must pay full sticker price for their Marketplace plan. A diabetic patient earning $63,500 can qualify for a credit worth hundreds to thousands of dollars per month.

For diabetic patients with variable income, managing MAGI carefully can determine whether you qualify for thousands in subsidies. If you are a self-employed diabetic patient filing Schedule C, deductible business expenses, half of self-employment tax, and the self-employed health insurance deduction (Form 7206 if applicable) all reduce MAGI. If you are a W-2 employee with diabetes, pretax 401(k) contributions and HSA contributions reduce MAGI. In both cases, staying below 400% FPL ($63,840 single in 2026) can mean the difference between a $0 net premium and a $1,200 per month premium. The Section 1095-A form from your Marketplace insurer is the document used to reconcile advance premium tax credits at tax time. Verify the 1095-A amounts match your records before filing.

• 138% FPL ($22,025 single in 2026): Medicaid expansion threshold in expansion states. At this income, Medicaid is often better than a Marketplace plan for a diabetic patient.
• 150% FPL ($23,940 single in 2026): Marketplace plan premium is capped at 0% of income. Net premium is $0 for a benchmark Silver plan.
• 250% FPL ($39,900 single in 2026): CSR eligibility cutoff. Above this income, cost-sharing reductions on Silver plans phase out.
• 400% FPL ($63,840 single in 2026): Subsidy cliff. At this income, PTC eligibility ends. Earning $1 more means $0 in premium tax credits.

HSA and HDHP fit for diabetic patients in 2026

A Health Savings Account (HSA) is available to any diabetic patient enrolled in an HSA-qualified High-Deductible Health Plan (HDHP). The 2026 HDHP minimum deductible is $1,700 for self-only coverage and $3,400 for family coverage. The 2026 HSA contribution limit is $4,400 for self-only and $8,750 for family coverage, plus a $1,000 catch-up contribution for anyone age 55 or older. The triple tax advantage of an HSA applies fully to diabetes-related expenses: contributions are tax-deductible above the line, the account grows tax-free, and qualified diabetes expenses are withdrawn tax-free. Qualified HSA expenses for a diabetic patient confirmed by IRS Publication 502 include insulin (all formulations, including OTC insulin purchased at a pharmacy), continuous glucose monitors (CGMs), blood glucose test strips, lancets, syringes, insulin pens, insulin pumps, and infusion sets.

A Flexible Spending Account (FSA) also covers the same diabetes expenses with pre-tax dollars, but an FSA is employer-sponsored only. Diabetic patients who are self-employed, gig workers with diabetes, or unemployed do not have access to an FSA. For those with employer-sponsored coverage, an FSA can be paired with a non-HDHP plan. If you have an HSA-qualified HDHP, you are NOT allowed to also have a general-purpose FSA. HSA dollars roll over year to year with no use-it-or-lose-it penalty, making an HSA a powerful long-term medical savings vehicle for a diabetic patient who expects ongoing supply costs for years or decades. Unlike an FSA, an HSA is portable: it stays with you when you change jobs or change insurance plans.

Self-employment health insurance deduction (Form 7206) for self-employed diabetic patients

Form 7206 applies only to diabetic patients who have net self-employment income and are not eligible for an employer-sponsored plan. If you are a self-employed diabetic patient, freelancer, or 1099 contractor with diabetes, Form 7206 allows you to deduct 100% of health insurance premiums paid for yourself, your spouse, and dependents as an above-the-line adjustment on Schedule 1, line 17. For a Type 1 diabetic paying $1,200 per month ($14,400 per year) in ACA Marketplace premiums, this deduction saves roughly $3,400 in federal income tax for a filer in the 24% bracket, plus reduces MAGI for next year's PTC calculation. The reduction in MAGI from the Form 7206 deduction can itself move a self-employed diabetic patient from above 400% FPL to below it, triggering Premium Tax Credit eligibility.

Two critical facts every self-employed diabetic patient must know about Form 7206: (1) The deduction reduces income tax and MAGI, but it does NOT reduce self-employment tax on Schedule SE. The 15.3% SE tax is calculated on net self-employment earnings before the health insurance deduction is applied. Never assume Form 7206 reduces both income tax and SE tax: that is factually incorrect and leads to underpayment of self-employment taxes. (2) Any month you or your spouse were eligible for an employer-sponsored plan disqualifies the deduction for that month. For W-2 employees, employed spouses on employer plans, college students on parent plans, or Medicare-enrolled diabetic patients over 65, Form 7206 does not apply. Those patients deduct medical expenses, if at all, as itemized deductions on Schedule A above 7.5% of AGI.

Medicare and Medicare Part D insulin coverage for diabetic patients in 2026

Diabetic patients age 65 and older (or under 65 with certain disabilities) enrolled in Medicare have meaningful insulin cost protections in 2026. Under the Inflation Reduction Act (signed August 16, 2022), Medicare Part D caps out-of-pocket insulin costs at $35 per monthly supply regardless of the insulin's tier placement on the plan formulary. This cap applies to any covered insulin that a diabetic patient takes for diabetes, including rapid-acting, long-acting, intermediate-acting, and inhaled insulin. The $35 monthly cap and the 2026 Medicare Part D out-of-pocket maximum of $2,100 make Medicare a strong option for older diabetic patients with high insulin costs. Medicare Part B also covers continuous glucose monitors classified as durable medical equipment for Type 1 diabetics and insulin-treated Type 2 diabetics.

Diabetic patients who are pre-65 (ages 60 to 64) and not yet eligible for Medicare should plan for the bridge years carefully. Early retirees with diabetes transitioning between employer coverage and Medicare have limited options: ACA Marketplace plans, COBRA, or a spouse's employer plan. An ACA plan for a 62-year-old diabetic patient with income below 400% FPL can be heavily subsidized through the Premium Tax Credit. At 63 or 64, the time horizon is short enough that COBRA at full price may make sense if mid-treatment with a specialist team. Medicare enrollment at 65 is not automatic for people who delayed claiming Social Security: most diabetic patients must actively enroll in Medicare Part B during the 7-month Initial Enrollment Period around their 65th birthday.

State insulin copay caps and programs for diabetic patients in 2026

As of 2026, 29 states have enacted some form of insulin copay cap for state-regulated health insurance plans. These state-level caps typically limit a 30-day supply of insulin to $25 to $35 for people enrolled in fully insured employer plans or individual market plans regulated by the state insurance commissioner. California caps insulin copays at $35 per 30-day supply for large group insurers effective January 1, 2026, and separately sells state-branded CalRx insulin at a maximum of $55 for a five-pack ($11 per pen) for uninsured Californians. Minnesota caps diabetes medication copays at $25 per month. Connecticut, Kentucky, Maryland, and Minnesota also have limits at $35 or below. Wisconsin enacted an insulin copay cap effective in 2026.

State insulin copay caps generally do NOT apply to self-funded employer plans (governed by ERISA, not state insurance law), Medicare Part D plans, or Medicaid. Diabetic patients covered by a self-funded employer plan must check their plan documents to understand insulin cost-sharing. The federal INSULIN Act of 2026, introduced in the Senate, would extend the $35 per month insulin cap to private insurance holders nationwide, but as of June 2026 it has not passed. The National Conference of State Legislatures (NCSL) maintains a current state-by-state tracker of insulin copay cap laws at ncsl.org. Diabetic patients should verify their specific state's current cap status before selecting a plan.

Marketplace Special Enrollment Period (SEP) triggers for people with diabetes

Diabetes itself is not a qualifying event for a Marketplace Special Enrollment Period. SEPs are triggered by changes in life circumstances, not health status. However, many of the events that most commonly affect a diabetic patient do qualify. The SEP window is generally 60 days from the date of the qualifying event to newly select or change Marketplace coverage. Missing this window means waiting until the next Open Enrollment Period (November 1 to January 15 for coverage starting January 1 or February 1, depending on when you enroll). For a diabetic patient who needs continuous insulin and CGM coverage, a gap in coverage even of 30 days can result in thousands of dollars in out-of-pocket supply costs.

Enrollment in a new Marketplace plan is effective on the first of the month following enrollment in most cases, creating a brief gap. For an insulin-dependent patient or Type 1 diabetic, work with your prescriber to have a 30-day emergency supply on hand when changing plans. Manufacturer patient assistance programs (Eli Lilly, Novo Nordisk, Sanofi all have programs) can bridge gaps in coverage. The HealthCare.gov enrollment portal at healthcare.gov/coverage-outside-open-enrollment/ lists all qualifying SEP events and the documentation required to verify each one.

• Loss of other health coverage (job loss, end of COBRA, loss of Medicaid or CHIP): 60-day SEP window. This is the most common trigger for diabetic patients.
• Getting married or entering a domestic partnership: 60-day SEP window. Income changes from marriage can affect PTC eligibility.
• Having a baby, adopting a child, or placing a child in foster care: 60-day SEP window.
• Permanently moving to a new state (or new area in the same state with different Marketplace options): 60-day SEP window. Diabetic patients moving must re-verify that their insulin formulation and CGM brand are on the new state's Marketplace plan formularies.
• Gaining or losing Medicaid or CHIP eligibility (including Medicaid redetermination): 60-day SEP window from the end of coverage date.
• Turning 26 and aging off a parent's plan: 60-day SEP window. Young adults with Type 1 diabetes aging off their parent's plan should begin Marketplace research 90 days before their birthday.
• Getting divorced and losing coverage through a spouse's employer plan: 60-day SEP window from the date coverage ends.

How to enroll in a health plan as a person with diabetes: step-by-step guide

Open Enrollment for 2026 coverage ran November 1 to January 15, 2026. Outside of Open Enrollment, people with diabetes can enroll only if they have a qualifying Special Enrollment Period event. The following steps apply whether you are enrolling for the first time, switching plans, or enrolling after a qualifying life event.

Step 1: Gather documents before going to HealthCare.gov. Documents needed: government-issued photo ID, Social Security numbers for all household members, income documentation (W-2s, 1099s, or a recent pay stub), proof of any qualifying SEP event (termination letter, COBRA notice, Medicaid denial letter, or moving documents), and a list of your current medications by brand name and dosage so you can check formulary coverage during plan comparison. Step 2: Go to healthcare.gov or your state exchange (Covered California, NY State of Health, Connect for Health Colorado, etc.) and create or log into your account. Step 3: Enter household size and projected 2026 income. The system will calculate your estimated Premium Tax Credit and show whether you may qualify for Medicaid or CSRs. Step 4: Compare plans. Filter for plans that include your insulin brand and CGM on the formulary. Use the Total Cost Estimator tool, which factors in your expected annual medical usage, not just the premium. Step 5: Verify your specific medications. Click through each plan to its formulary and search by drug name. Confirm your insulin formulation and CGM brand are covered at an acceptable tier. Step 6: Enroll and pay the first premium. Coverage is not active until the first premium payment clears. Keep your first payment confirmation as proof of coverage start date.

• Common reasons applications are denied or delayed: income documentation mismatch, SEP event not verified within the system, household size discrepancy with IRS records, Social Security number errors, or duplicate enrollment attempt.
• Documents needed checklist: (1) government-issued photo ID; (2) Social Security number for each household member; (3) most recent 1099 or W-2 income documents; (4) SEP event documentation if applicable; (5) current medication list with brand names and dosages; (6) current insurer's COBRA or termination notice if losing other coverage.

What is the cheapest health insurance for a person with diabetes in 2026?

The cheapest plan depends on income. For a diabetic patient earning under 250% FPL ($39,900 single in 2026), a Silver plan with cost-sharing reductions almost always provides the lowest total cost, despite having a higher premium than Bronze, because the deductible and out-of-pocket maximum drop dramatically. At very low incomes (under 138% FPL in expansion states), Medicaid is free and covers insulin and CGMs with $0 to $4 copays. For higher earners above the 400% FPL subsidy cliff ($63,840 single), an HSA-qualified HDHP with maxed HSA contributions reduces tax liability and can lower net cost. The worst choice for most diabetic patients is Bronze when income is under 250% FPL, because the high deductible costs more than the premium savings.

Do people with diabetes qualify for the Premium Tax Credit (PTC) in 2026?

Yes. Having Type 1 diabetes, Type 2 diabetes, or any other pre-existing condition does not affect PTC eligibility in any way. PTC eligibility is based entirely on household income as a percentage of the Federal Poverty Level (FPL). In 2026, the enhanced PTCs from ARPA/IRA expired, and subsidies phase down approaching 400% FPL and stop at 400% FPL ($63,840 single, $132,000 family of four). A diabetic patient earning $63,500 qualifies for premium credits; the same patient earning $64,000 receives $0 in credits. Managing MAGI by maximizing retirement contributions, HSA contributions, and the Form 7206 deduction (if self-employed) can keep a diabetic patient below the cliff.

Can a diabetic patient deduct health insurance premiums on their taxes?

It depends on employment type. Self-employed diabetic patients with net self-employment income can deduct 100% of premiums above the line using Form 7206, which reduces both income tax and MAGI but does NOT reduce self-employment tax on Schedule SE. The 15.3% SE tax is calculated before the health insurance deduction applies. W-2 employees with diabetes typically pay pretax premiums through payroll (Section 125 cafeteria plan), which achieves a similar tax benefit. Diabetic patients who are neither self-employed nor on an employer plan can deduct premiums as a medical expense on Schedule A only above 7.5% of AGI, which is a much higher bar. Form 7206 does not apply to W-2 workers, Medicare-enrolled patients, or diabetic patients on a parent's plan.

Can a diabetic patient use an HSA for insulin and CGMs?

Yes, HSA funds cover all common diabetes expenses tax-free. Confirmed IRS-eligible items include insulin (all formulations, including OTC), continuous glucose monitors (CGMs) including Dexcom, FreeStyle Libre, and Medtronic devices, blood glucose test strips, lancets, syringes, insulin pens, insulin pumps, and pump supplies. The 2026 HSA contribution limit is $4,400 self-only or $8,750 family (plus $1,000 catch-up at age 55+). To contribute to an HSA, you must be enrolled in an HDHP with a minimum deductible of $1,700 self or $3,400 family in 2026. FSA accounts also cover the same diabetes expenses but are employer-only: self-employed diabetic patients and gig workers with diabetes cannot open a standalone FSA.

What if a diabetic patient makes too much for subsidies?

Above 400% FPL ($63,840 single, $132,000 for a family of four in 2026), the Premium Tax Credit phases out entirely and you pay full sticker price for any Marketplace plan. Strategies to manage high cost: (1) an HSA-qualified HDHP has the lowest sticker premium and opens HSA tax deductions of up to $4,400 self or $8,750 family; (2) maximizing a 401(k), SEP-IRA, or Solo 401(k) reduces MAGI and may bring you back below 400% FPL; (3) Form 7206 (for self-employed diabetic patients) reduces MAGI with the premium itself; (4) compare total annual cost across plan tiers using the Marketplace Total Cost Estimator, not just monthly premiums.

When can a diabetic patient enroll in a Marketplace plan outside Open Enrollment?

Diabetic patients can enroll outside Open Enrollment only after a qualifying life event triggers a Special Enrollment Period (SEP). The SEP window is 60 days from the qualifying event. Common events for diabetic patients include losing employer coverage (job loss), aging off a parent's plan at 26, losing Medicaid or CHIP eligibility, getting married or divorced, having a baby, or moving to a new state. Diabetes itself is not a qualifying event. For an insulin-dependent patient or Type 1 diabetic, a lapse in coverage means paying full retail for insulin, so act within the 60-day window. Go to healthcare.gov/coverage-outside-open-enrollment to check your SEP eligibility and begin enrollment.

Does Medicare cover insulin and CGMs for diabetic patients?

Yes. Under the Inflation Reduction Act (signed August 16, 2022), Medicare Part D caps out-of-pocket insulin costs at $35 per monthly supply for enrolled beneficiaries in 2026. The 2026 Medicare Part D out-of-pocket maximum is $2,100, which limits total drug cost exposure for high-cost insulin users. Medicare Part B covers CGMs as durable medical equipment for Type 1 diabetics and insulin-treated Type 2 diabetics. Beneficiaries must use a Medicare-enrolled supplier and meet documentation requirements. Medicare Advantage plans (Part C) must cover the same drug benefits as Original Medicare, and many offer additional diabetes disease management programs.

Does my state cap insulin copays for diabetic patients?

As of 2026, 29 states have enacted some form of insulin copay cap for state-regulated health insurance plans, with most caps ranging from $25 to $35 per 30-day supply. California caps insulin copays at $35 for large group plans as of January 1, 2026, and offers CalRx state-brand insulin at $11 per pen for uninsured residents. Minnesota caps at $25 per month for diabetes medications. State caps generally do not apply to self-funded employer plans (ERISA-governed), Medicare Part D, or Medicaid. Check your specific state's current law at the NCSL diabetes state mandates tracker (ncsl.org). If your state has not enacted a cap, manufacturer patient assistance programs from Eli Lilly (Lilly Cares), Novo Nordisk (Patient Assistance Program), and Sanofi can reduce or eliminate out-of-pocket insulin costs.

Can a diabetic patient enroll in a catastrophic plan?

A catastrophic plan is available only to people under age 30 OR people who qualify for a hardship exemption. A diabetes diagnosis alone does not qualify as a hardship exemption for catastrophic plan eligibility. For a Type 1 diabetic or insulin-dependent patient under age 30, a catastrophic plan has the lowest monthly premium but a deductible equal to the 2026 ACA out-of-pocket maximum of $10,600 per individual, meaning you pay full cost for all insulin, CGMs, and supplies until hitting that threshold. For most diabetic patients with ongoing Rx and supply needs, a catastrophic plan is not the right choice: the annual out-of-pocket cost under a catastrophic plan will exceed total cost under a Silver plan with cost-sharing reductions at nearly any income level under 250% FPL. Diabetic patients over age 30 without a hardship exemption are not eligible for a catastrophic plan.